Living Cell Technologies Ltd. (AU:1AI) has released an update.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Algorae Pharmaceuticals has expanded its therapeutic pipeline with 24 new AI-generated drug targets for preclinical evaluation, focusing on oncology indications with unmet needs. This development, facilitated by their proprietary AlgoraeOS platform, underscores the company’s competitive edge in AI-driven drug discovery. Successful preclinical outcomes may lead to further development, potentially in collaboration with other pharmaceutical firms.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.